Safety and Reactogenicity of Bioconjugate Vaccine to Prevent Shigella
This study has been completed.
Sponsor:
GlycoVaxyn AG
Information provided by:
GlycoVaxyn AG
ClinicalTrials.gov Identifier:
NCT01069471
First received: February 15, 2010
Last updated: October 11, 2010
Last verified: October 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | October 2010 |
| Primary Completion Date: | October 2010 (Final data collection date for primary outcome measure) |